Characterization of the binding of MRTX1133 as an avenue for the discovery of potential KRASG12D inhibitors for cancer therapy

Abdul Rashid Issahaku(University of KwaZulu-Natal), Johra Khan(Majmaah University), Sami G. Almalki(Creighton University), Clement Agoni(University of KwaZulu-Natal), Sahar M. Aldosari(Majmaah University), Namutula Mukelabai(University of KwaZulu-Natal), Mithun Rudrapal(Vignan's Foundation for Science, Technology & Research)
Scientific Reports
October 22, 2022
Cited by 94


Related Papers